Gainers
- Revlon, Inc. REV jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.
- Grove Collaborative Holdings, Inc. GROV rose 67.9% to close at $10.00. Grove Collaborative and Virgin Group Acquisition Corp. II announced the completion of their previously announced business combination.
- Mereo BioPharma Group plc MREO gained 62.5% to close at $1.30. AstraZeneca is rumored to be eyeing takeover of Mereo BioPharma Group, according to a report in The Times.
- SoundHound AI, Inc. SOUN climbed 49.8% to close at $4.44.
- Swvl Holdings Corp. SWVL gained 35.3% to settle at $6.90.
- Clovis Oncology, Inc. CLVS surged 31.9% to close at $1.18. Clovis Oncology recently announced a presentation detailing initial Phase 1 data from Phase 1/2 LuMIERE clinical study of FAP-2286 labeled with lutetium-177 (177Lu-FAP-2286).
- Jupiter Wellness, Inc. JUPW jumped 31.4% to close at $0.80. Jupiter Wellness retired approximately 10% of its outstanding shares.
- Satellogic Inc. SATL jumped 29.6% to close at $5.04.
- Electric Last Mile Solutions, Inc. ELMS gained 29.4% to close at $0.3650 after jumping 100% on Thursday.
- Sesen Bio, Inc. SESN climbed 29.2% to close at $0.76.
- Corbus Pharmaceuticals Holdings, Inc. CRBP jumped 28.8% to close at $0.3002.
- Virgin Orbit Holdings, Inc. VORB gained 28.1% to close at $3.51.
- Cipher Mining Inc. CIFR gained 27.3% to settle at $1.82.
- Comera Life Sciences Holdings, Inc. CMRA gained 26.9% to close at $4.44. Comera was granted U.S. patent titled 'Excipient compounds for protein processing.'
- Clear Channel Outdoor Holdings, Inc. CCO jumped 26.6% to settle at $1.38.
- Tivic Health Systems, Inc. TIVC rose 26.3% to close at $2.40. Tivic Health Systems, during May, reported a Q1 loss of $0.23 per share.
- Starry Group Holdings, Inc. STRY gained 26% to close at $5.18. Cowen & Co. initiated coverage on Starry Group Holdings with an Outperform rating and announced a price target of $9.
- XpresSpa Group, Inc. XSPA gained 24.6% to close at $0.86.
- Secoo Holding Limited SECO rose 24% to settle at $0.2874. Secoo received approval to transfer to Nasdaq Capital Market.
- Symbotic Inc. SYM gained 23.8% to close at $16.80.
- Altimmune, Inc. ALT surged 22.9% to settle at $9.02.
- Pharvaris N.V. PHVS jumped 22.1% to close at $27.50.
- Virco Mfg. Corporation VIRC gained 21.9% to close at $3.67.
- MINISO Group Holding Limited MNSO climbed 21.8% to close at $7.67.
- Sana Biotechnology, Inc. SANA gained 21.5% to close at $5.15.
- Jerash Holdings (US), Inc. JRSH jumped 20.2% to settle at $6.70. Jerash Holdings’ board recently authorized a $3 million buyback.
- Crexendo, Inc. CXDO surged 20.1% to settle at $3.23.
- Lyell Immunopharma, Inc. LYEL jumped 20% to close at $5.46.
- PhaseBio Pharmaceuticals, Inc. PHAS rose 19.8% to close at $0.6201.
- Zai Lab Limited ZLAB jumped 19.8% to close at $27.73. Zai Lab recently announced breakthrough therapy designations granted for Repotrectinib in China.
- Rocky Mountain Chocolate Factory, Inc. RMCF jumped 19.6% to settle at $8.25. Rocky Mountain Chocolate, last month, posted Q4 EPS of $0.01.
- Centessa Pharmaceuticals plc CNTA gained 19.1% to close at $4.93 after BRMO Capital initiated coverage on the stock with an Outperform rating and $19 price target.
- Sonder Holdings Inc. SOND surged 18.8% to close at $1.52.
- Helbiz, Inc. HLBZ climbed 18.6% to close at $0.83.
- REE Automotive Ltd. REE jumped 18.6% to close at $1.53.
- Rubius Therapeutics, Inc. RUBY gained 18.4% to settle at $0.9323.
- Lilium N.V. LILM gained 18% to close at $2.69.
- Heritage Global Inc. HGBL jumped 17.8% to close at $1.55.
- Cogent Biosciences, Inc. COGT jumped 17.8% to close at $9.19. Cogent Biosciences recently announced a proposed public offering of $125 million of common stock.
- Q&K International Group Limited QK gained 17.7% to settle at $1.60.
- Velocity Financial, Inc. VEL rose 17.6% to close at $11.64.
- BridgeBio Pharma, Inc. BBIO gained 17.5% to close at $7.65.
- Mersana Therapeutics, Inc. MRSN jumped 17.5% to close at $3.70.
- Akero Therapeutics, Inc. AKRO surged 17.3% to settle at $12.16. Akero Therapeutics announced a $25 million equity investment by Pfizer at $9.90 per share.
- Quotient Limited QTNT gained 17.2% to settle at $0.3599.
- Dyne Therapeutics, Inc. DYN rose 17.2% to close at $5.94.
- Synlogic, Inc. SYBX surged 16.6% to close at $1.04.
- Bit Digital, Inc. BTBT jumped 16.4% to close at $1.42.
- Allogene Therapeutics, Inc. ALLO gained 16.4% to close at $ 10.96.
- Allogene Therapeutics recently said that the FDA granted regenerative medicine advanced therapy designation to ALLO-501A for Large B Cell Lymphoma.
- Stem, Inc. STEM rose 16.4% to settle at $7.30.
- bluebird bio, Inc. BLUE shares gained 16.3% to close at $3.56. The FDA's Advisory Committee recently unanimously backed Bluebird bio’s gene therapy for a rare blood disorder.
- Atara Biotherapeutics, Inc. ATRA rose 16.2% to close at $5.87.
- Scopus BioPharma Inc. SCPS jumped 15.9% to settle at $0.4250.
- Vaxart, Inc. VXRT gained 15.6% to close at $3.12.
- Recursion Pharmaceuticals, Inc. RXRX jumped 15.3% to close at $7.62.
- Allakos Inc. ALLK gained 14.2% to close at $2.97.
- Kinnate Biopharma Inc. KNTE rose 13.7% to close at $9.36.
- Seagen Inc. SGEN shares rose 12.7% to close at $165.45. Merck is eyeing purchase of biotech Seagen, while other unnamed suitors are also eyeing Seagen, the Wall Street Journal said.
- Calliditas Therapeutics AB CALT rose 12% to close at $17.82.
- Scholar Rock Holding Corporation SRRK shares rose 10.9% to close at $5.39. Scholar Rock reported Phase 2 topaz trial extension data showing 'sizable and sustained motor function improvement at 24 months with apitegromab for non-ambulatory patients with types 2 and 3 spinal muscular atrophy.'
- Sapiens International Corporation N.V. SPNS climbed 10.9% to close at $23.22.
- Sight Sciences, Inc. SGHT jumped 10.4% to close at $8.27.
- Surrozen, Inc. SRZN gained 8.6% to close at $2.41. Surrozen recently initiated dosing in Phase 1 clinical trial of SZN-043 for severe alcoholic hepatitis.
Losers
- Renovare Environmental, Inc RENO fell 64.7% to close at $0.06 on Friday.
- Addex Therapeutics Ltd ADXN shares declined 58.3% to settle at $1.50 after the company terminated its Phase 2b/3 study of Dipraglurant for dyskinesia associated with Parkinson's disease due to slow recruitment. The company suspended its guidance amid the termination.
- ToughBuilt Industries, Inc. TBLT fell 51.5% to close at $1.48 after the company priced a $6 million offering.
- Advent Technologies Holdings, Inc. ADN declined 27.6% to close at $2.89. Advent Technologies recently announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
- Bon Natural Life Limited BON fell 23% to close at $2.85.
- Axcella Health Inc. AXLA dropped 22.7% to close at $1.80.
- Pennsylvania Real Estate Investment Trust PEI shares declined 20.5% to close at $4.23.
- Sidus Space, Inc. SIDU fell 19.3% to close at $6.16.
- Equillium, Inc. EQ declined 16.7% to settle at $1.75.
- NeuroPace, Inc.NPCE fell 16% to close at $5.03.
- Tabula Rasa HealthCare, Inc. TRHC dropped 15.7% to close at $2.42.
- Innate Pharma S.A. IPHA fell 15.3% to close at $2.00.
- Applied UV, Inc. AUVI declined 15.2% to close at $2.45.
- AN2 Therapeutics, Inc. ANTX fell 15.1% to settle at $8.51.
- Neptune Wellness Solutions Inc. NEPT declined 14.7% to close at $2.32. Neptune Wellness appointed Raymond Silcock as Chief Financial Officer.
- Vertex Energy, Inc. VTNR fell 14.5% to settle at $11.82.
- Mesa Royalty Trust MTR declined 14.5% to close at $14.96.
- Northern Oil and Gas, Inc. NOG fell 14.4% to close at $27.52.
- Hillstream BioPharma, Inc. HILS dropped 14.4% to close at $0.78.
- Alvotech Ordinary Shares ALVO fell 14.1% to close at $9.70.
- Heart Test Laboratories, Inc. HSCS dropped 14.1% to close at $2.0777. Heart Test Laboratories announced pricing of its IPO of 1.5 million units at a price of $4.25 per unit.
- Athersys, Inc. ATHX fell 12.9% to close at $0.2789 after dropping more than 12% on Thursday.
- Calumet Specialty Products Partners, L.P. CLMT declined 12.1% to close at $10.15.
- Vivakor, Inc. VIVK fell 10.4% to close at $2.23. Vivakor shares jumped 40% on Thursday after the company announced it signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City.
- Dream Finders Homes, Inc. DFH dipped 10% to close at $10.64. B of A Securities downgraded Dream Finders Homes from Neutral to Underperform and lowered the price target from $18 to $10.5.
- Range Resources Corporation RRC fell 9.9% to close at $26.29.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsIntegrated Telecommunication ServicesMovers From YesterdayTelecommunication ServicesTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in